PROKIDNEY CORP. — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2022-12-01

Reporting Person: Weger Mary (Chief People Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-01	Employee stock option (right to buy)	$10.25	A	450000	Acquired	2032-12-01	Class A Ordinary Shares (450000)	Direct

Footnotes

F1: The right to purchase common stock vests over four years as follows: 25% on December 1, 2023 and the remaining 75% in substantially equal monthly installments over a 36 month period beginning on December 1, 2023.